Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-16-085018
Filing Date
2016-02-29
Accepted
2016-02-29 17:00:03
Documents
82
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v431942_10k.htm 10-K 996920
2 EXHIBIT 23.1 v431942_ex23-1.htm EX-23.1 2452
3 EXHIBIT 31.1 v431942_ex31-1.htm EX-31.1 10302
4 EXHIBIT 31.2 v431942_ex31-2.htm EX-31.2 10305
5 EXHIBIT 32 v431942_ex32.htm EX-32 5430
  Complete submission text file 0001144204-16-085018.txt   7553412

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acur-20151231.xml EX-101.INS 1794518
7 XBRL TAXONOMY EXTENSION SCHEMA acur-20151231.xsd EX-101.SCH 72419
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20151231_cal.xml EX-101.CAL 60227
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20151231_def.xml EX-101.DEF 414175
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20151231_lab.xml EX-101.LAB 518763
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20151231_pre.xml EX-101.PRE 485438
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

EIN.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10113 | Film No.: 161469157
SIC: 2834 Pharmaceutical Preparations